Lipid-lowering drug targets and lung related diseases: a Mendelian randomization study
OBJECTIVES This genetics-based study aimed to evaluate the relationships of long-term lipid-lowering agents on lung-related diseases (LRD) outcomes. METHODS We extracted genetic variations of six drug target genes from a major genome-wide association study of low-density lipoprotein cholesterol (LDL...
Saved in:
| Main Authors: | Haifeng Yu, Xiaofei Zhang, Bian Wen, Shuo Hu, Bin Ni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | All Life |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/26895293.2024.2329440 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between lipid-lowering drug targets and the risk of cystic kidney disease: a drug-target Mendelian randomization analysis
by: Zhiwen Lian, et al.
Published: (2025-12-01) -
Lipid‐Lowering Drugs and Pulmonary Vascular Disease: A Mendelian Randomization Study
by: Xingya Yuan, et al.
Published: (2025-01-01) -
Lipid-lowering drug targets associated with risk of respiratory disease: a Mendelian randomization study
by: Zhipeng Gong, et al.
Published: (2025-02-01) -
Genetic association of lipids and lipid-lowering drug target genes with breast cancer
by: Tianhua Wang, et al.
Published: (2025-03-01) -
Associations Between Lipids and Lipid‐Lowering Drug Target Genes and Osteomyelitis: A Mendelian Randomization Analysis
by: Zhiyi Zhou, et al.
Published: (2025-06-01)